与康复性血治疗的COVID-19疾病住院患者死亡率相关的因素
Armando M Perichon1, Andrea Acosta2, Liliana Di Tulio2
1Centro Único de Donación, Ablación e Implante de Órganos, Ministerio de Salud, Rosario, Santa Fe, Argentina.
mBio
|November 8, 2023
概括
早期康复性血 (CP) 治疗严重的COVID-19可能会降低死亡率. 这种疗法是一种潜在的安全,具有成本效益的选择,特别是当抗病毒药物无法使用时.
科学领域:
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
- 关键护理医学 关键护理医学
背景情况:
- 康复性等离子体 (CP) 正被探索为一种COVID-19治疗方法,特别是在资源有限的环境中.
- 目前的FDA指导方针限制CP的使用在特定的免疫功能低下的患者群体中,这些患者的抗体水平已被证实为高.
- 虽然许多试验在住院患者中显示出有限的益处,但早期管理可能是有效的.
研究的目的:
- 评估早期CP给药对严重COVID-19患者死亡率的影响.
- 评估CP作为治疗选择的安全性和成本效益.
主要方法:
- 追溯性研究设计.
- 分析患者数据,比较早期 (住院3天内) 与晚期CP治疗.
- 对28天死亡率的评估.
主要成果:
- 早期CP治疗 (住院后3天内) 与28天死亡率的降低有显著关联.
- CP被证明是一个相对安全和廉价的治疗选择.
- 结果支持CP在特定严重的SARS-CoV-2感染患者中的潜在疗效.
结论:
- 早期给予康复期血可能会改善严重COVID-19患者的治疗结果.
- 康复性血是一种可行的,具有成本效益的治疗选择,特别是在缺乏抗病毒药物的地区.
- 进一步的证据支持使用CP来管理严重的SARS-CoV-2感染.
相关概念视频
01:28Pneumonia IV: Management
338
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
338
01:30Pneumonia III: Complications and Assessment
241
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
241
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10